Optimizing Drug-Resistant Tuberculosis Treatment Outcomes in a High HIV-Burden Setting: A Study of Sputum Conversion and Regimen Efficacy in Rural South Africa
Pathogens · 2025
DOI: 10.3390/pathogens14050441 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2025. Verfasst von Mojisola Clara Hosu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Faculty of Medicine and Health Sciences, Walter Sisulu University, Private Bag X5117, Mthatha 5099, …. Hauptthemen laut MEDLINE: Tuberculosis, Multidrug-Resistant, Sputum, Antitubercular Agents, HIV Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: South African Medical Research Council, Walter Sisulu University.
Abstract (Originalsprache)
Background
Sputum culture and smear conversion are key indicators of treatment response in drug-resistant tuberculosis (DR-TB). This study aimed to assess sputum conversion and regimen efficacy among DR-TB patients and identify factors influencing conversion rates.
Methods
This retrospective cohort study analyzed medical records of DR-TB patients treated between 2018 and 2020 in the Eastern Cape Province, South Africa. Kaplan–Meier curves, Spearman correlation, and logistic regression models were used to assess time-to-sputum conversion and its predictors.
Results
Among the 88% of patients who achieved sputum conversion, the median time ranged from 29 to 59 days. Patients on short treatment regimens converted significantly faster than those on long regimens (p = 7.55 × 10−15), with 90% of short-regimen patients achieving favorable outcomes compared to 52% in the long regimen group (p = 0.0000040). Spearman correlation revealed a weak but significant positive association between comorbidities and conversion time (r = 0.041, p = 0.041). HIV-positive patients had a slower conversion rate than HIV-negative patients, but this association was not statistically significant (χ2 = 0.426, p = 0.514). Logistic regression identified older age as a predictor of favorable outcomes (coefficient = 0.039, p = 0.045), while regimen type and HIV status did not show significant predictive power.
Conclusions
Shorter treatment regimens significantly improve sputum conversion rates and treatment outcomes. The findings support optimizing DR-TB treatment through personalized regimens based on patient health status and drug resistance patterns. This study provides evidence to enhance TB control efforts in high-burden regions, with implications for global treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Pathology, Faculty of Medicine and Health Sciences, Walter Sisulu University, Private Bag X5117, Mthatha 5099, South Africa.
ORCID-Profile: Mojisola Clara Hosu, Lindiwe Modest Faye, Teke Apalata
Förderung
- South African Medical Research Council
- Walter Sisulu University
Zitieren
APA
Hosu, M. C., Faye, L. M., & Apalata, T. (2025). Optimizing Drug-Resistant Tuberculosis Treatment Outcomes in a High HIV-Burden Setting: A Study of Sputum Conversion and Regimen Efficacy in Rural South Africa. Pathogens. https://doi.org/10.3390/pathogens14050441
Vancouver
Hosu MC, Faye LM, Apalata T. Optimizing Drug-Resistant Tuberculosis Treatment Outcomes in a High HIV-Burden Setting: A Study of Sputum Conversion and Regimen Efficacy in Rural South Africa. Pathogens. 2025. doi:10.3390/pathogens14050441
BibTeX
@article{Hosu2025,
author = {Hosu, Mojisola Clara and Faye, Lindiwe Modest and Apalata, Teke},
title = {Optimizing Drug-Resistant Tuberculosis Treatment Outcomes in a High HIV-Burden Setting: A Study of Sputum Conversion and Regimen Efficacy in Rural South Africa},
journal = {Pathogens},
year = {2025},
doi = {10.3390/pathogens14050441}
}
EUVIMED